Ethically Allocating COVID-19 Drugs Via Pre-approval Access and Emergency Use Authorization

• Published in: American journal of bioethics Vol. 20; no. 9; pp. 4 - 17
• Main Authors: Webb, Jamie, Shah, Lesha D., Lynch, Holly Fernandez
• Format: Journal Article
• Language: English
• Published: Taylor & Francis 01.09.2020
• Subjects: Biomedical research; health policy; human subjects research; pharmaceutical industry; rationing/resource allocation; research ethics

Allocating access to unapproved COVID-19 drugs available via Pre-Approval Access pathways or Emergency Use Authorization raises unique challenges at the intersection of clinical care and research. In conditions of scarcity, prioritization approaches should minimize harm, maximize benefit, and promot...